Tag: International Progressive MS Alliance
Global webcast: what we are learning from clinical trials
How all trials, successful or not, inform future research
Global webcast on mobility challenges in progressive MS
Research to monitor and maximise mobility
Catch-up on the Progressive MS Alliance webcasts
Advances in treatment and research.
Global webcast on new treatments for progressive MS
Recent advances and promising researches
Global webcast on cognitive challenges in progressive MS
Catch up on advances in treatment and research.
Global webcast on ending MS progression
Research advances that could lead to breakthrough treatments in progressive MS
Why is it important for people affected by MS to be actively involved in research?
New survey launched by the International Progressive MS Alliance
€3 million to advance research in stopping MS progression
International Progressive MS Alliance invests €3 million in drug discovery project to develop therapies to stop MS progression.
Global webcast on pain in progressive MS
Answering questions and exploring advances in research
Solving the mystery of progression: the key to new treatments for progressive MS
Catch up with the latest webcast on unraveling the mystery of progression and identifying new targets for treatments
Global webcast on ending progressive MS
Learn about important, new research initiatives that will fuel the development of breakthrough treatments for progressive MS.
Could a blood test measuring Neurofilament light chain levels predict future MS activity?
A study funded by the International Progressive MS Alliance shows a blood test may have potential in helping to predict future MS activity and response to therapy.
Answering questions on fatigue in progressive MS
Catch up on the latest webcast on fatigue treatment and research from the International Progressive MS Alliance
Mapping out the global research agenda to end progressive MS
Leaders of the International Progressive MS Alliance have published a paper proposing a global research strategy to prioritise and coordinate the efforts needed to find more and better treatments, and improve quality of life of people living with progressive MS.
Winner of the 2021 Young Investigator Award
Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS
Progressive MS Alliance – MS stories from across the world
Find out about the lives of seven people affected by progressive MS.
FDA backs further research into ‘neurofilament light chain’
The regulatory agency’s Letter of Support will stimulate more studies that advance development and validation of the biomarker ‘neurofilament light chain’
Professor Alan Thompson wins the prestigious MS Charcot Award
Professor Thompson wins the 2021 lifetime achievement award for outstanding research into the understanding and treatment of MS
Alliance funds 19 Research Challenge Awards looking for answers on progression
In time for World MS Day, €1,425,000 has been awarded to help identify new therapeutic targets in progressive MS
Answering questions on progressive MS treatment and research
Watch the International Progressive MS Alliance webcast
Catch up on the latest breakthroughs in progressive MS treatments
A first-of-its-kind global research network funded by the International Progressive MS Alliance aims to develop new, effective treatments for progressive MS.
Progressive MS and accelerating breakthough treatments
Global webcast on 4 March
Research on fighting MS brain inflammation with information from the gut
This paper was first published in Nature January 2021
Join the discussion on symptom management & well-being in progressive MS
Register for the Progressive MS Alliance's Facebook Live event
A potential biomarker for progressive MS
The use of neurofilament light chain (NfL) as a biomarker could revolutionise clinical trials in progressive MS.
How do we accelerate life-changing treatments for people with progressive MS?
Join the discussion about research breakthroughs that could accelerate new treatments for people with progressive MS
Super-charging mitochondria – a potential pathway to treat progressive MS
New research funded by the International Progressive MS Alliance looks at ways that nerve fibres protect themselves from damage.
Answering today’s big questions in progressive MS
Watch the International Progressive MS Alliance webcast here
Discovering life-changing treatments for progressive MS
An International Progressive MS Alliance global webcast
Let’s talk about symptoms and well-being in progressive MS
Register for the Progressive MS Alliance's Facebook Live event on symptom management and well-being in progressive MS
Challenges in Progressive MS Awards: taking risks to reap rewards
Progressive MS Awards
First MS organisation in Latin America joins the Progressive MS Alliance
The International Progressive MS Alliance is growing!
Global webcast on solving progressive MS: progress achieved and hope for the future
Results released from first multi-drug clinical trial in MS
The results of the MS-SMART trial, an innovative trial testing multiple drugs at the same time, have ruled out three repurposed drugs for the treatment of progressive MS.
Blocking blood protein could protect nerves in MS
A treatment that blocks a type of protein that accumulates in the brain was able to reduce inflammation and damage to nerves in laboratory models of MS.
Making a difference through rehab research at the Progressive MS Alliance Conference
Researchers, clinicians and people living with MS, from around the world converged on the city of Toronto in Canada for the 3rd Congress of the International Progressive MS Alliance.
MS International Federation’s members gather in London to mark 50 years of the global MSIF movement
More than 100 staff, volunteers, and people with and affected by MS from 39 countries gathered in London in September for the MSIF Movement’s 50th Anniversary meetings.
Alliance holds pivotal London meeting
A meeting of minds took place at the recent International Progressive MS Alliance event in London
Celebrating the role of new technologies in transforming the lives of people affected by MS
Matthew Miles, Chief Executive of MS Research Australia, shared insights on how technology is revolutionising research, treatment, diagnosis, and more